Decoding Your DNA: An Updated Guide to HLA Nomenclature
"New Discoveries in the HLA System: What the May 2018 Update Means for You"
The human leukocyte antigen (HLA) system is a crucial part of our immune system, helping our bodies distinguish between self and non-self. Understanding the HLA system is vital in various fields, from organ transplantation to disease susceptibility and personalized medicine. Because the HLA system is highly diverse, with new variations being discovered regularly, keeping up with the latest nomenclature is essential for researchers, clinicians, and anyone interested in genetics and health.
This article breaks down the May 2018 update to the HLA nomenclature, providing clear explanations of the new allele assignments and their potential implications. By translating complex scientific information into accessible language, we aim to empower you with the knowledge to better understand your own genetic makeup and its role in your health.
This guide will cover the newly assigned sequences (Table 1) and confirmations of previously reported sequences (Table 2). The accession number of each sequence is given, and these can be used to retrieve the sequence files from the EMBL, GenBank or DDBJ data libraries.
The Official HLA Sequence Registry and Its Ongoing Updates
The official repository for HLA sequence data is the IPD-IMGT/HLA Database at EMBL-EBI, a specialist database for sequences of the human major histocompatibility complex (MHC) that includes the official sequences named by the WHO Nomenclature Committee for Factors of the HLA System. Originally part of the international ImMunoGeneTics (IMGT) project, the database now serves as the field's central sequence registry. The most recent formal guidance, 'Nomenclature for Factors of the HLA System' (2026), documents additions and revisions to HLA specificities, noting that the WHO committee met most recently in September 2023 to discuss additions to the serologically defined HLA antigens. Historical nomenclature reports are also archived on the project's nomenclature reports page, with freely available PDFs of the Tissue Antigens publications where possible.
Gold-Standard Typing Methods and the Complexity They Must Handle
The enormous amount of variation in the HLA genes has repeatedly pushed clinical laboratories away from one typing method and toward another better suited to characterizing that complexity. Today, the recognized gold standard for HLA typing consists of methods that can produce definitive HLA typing results, according to a June 2024 review of HLA typing methodologies and their clinical impact. Broader summaries describe HLA typing as enabling precise decision-making in clinical tissue matching, disease susceptibility assessment, and drug response prediction, given the HLA system's role in autoimmune reactions, transplant rejection, and related diseases. The hla.alleles.org resource, updated with new pages following the 2026 HLA Nomenclature Report, remains a comprehensive reference for HLA and HLA-related genes.
From Mouse H-2 to Human HLA
The human leukocyte antigen (HLA) system is a complex of genes on chromosome 6 that encode cell-surface proteins responsible for regulating the immune system. The naming of HLA antigens is deeply rooted in the discovery history of their serotypes and alleles, and the terminology can indeed be bewildering because it reflects both complex genetics and the way these antigens were originally characterized. A historical perspective traces the field from the earliest attempts at cancer transfers between mice, through the discovery of the mouse H-2 system on red blood cells and the identification of HLA class I and II antigens using sera from multiparous women, to the resolution of the functions explained by HLA and H-2. As overviews of the subject note, grasping this history helps make sense of the current system, even as questions of how to clean up the naming system remain open to debate.
What's New in the HLA Update? A Simplified Overview
The Nomenclature Committee continuously updates the HLA system to reflect new discoveries and refine existing classifications. The May 2018 update includes a range of newly assigned sequences and confirmations of previously reported sequences. These updates are crucial for maintaining accuracy and consistency in HLA typing.
- New Allele Designations: The update introduces official allele designations for sequences submitted since April 2018. These designations follow the established policies of the Nomenclature Committee.
- Sequence Accession Numbers: Each newly assigned sequence is given an accession number, allowing easy retrieval from data libraries like EMBL, GenBank, and DDBJ.
- Submitting Author Information: The update provides details of the submitting authors, essential for direct contact if a sequence hasn't been released yet.
- New HLA Sequences Table: A listing of the newly assigned sequences (Table 1), including the HLA allele, cell identification, accession number, and submitting author.
- Confirmatory Sequences Table: A listing of confirmations of previously reported sequences (Table 2).
Centralized Sequence Submission Takes Effect
The most recent nomenclature update specifies that all new and confirmatory sequences should now be submitted directly to the WHO Nomenclature Committee for Factors of the HLA System via the IPD-IMGT/HLA Database, using the sequence submission tool provided. The update cites prior work by Barker et al. (2023) and Robinson, Barker, and Marsh (2024) as the basis for this submission pathway. The change effectively centralizes official allele registration at a single database, tightening the link between sequence discovery and formal nomenclature.
Criticisms of the Naming System
Despite decades of refinement, the HLA nomenclature system is not without critics. Its layered structure, built up as technologies shifted from serology to DNA sequencing, can strike even experienced users as confusing, and some have argued for a cleaner, more user-friendly naming scheme. Any reform, however, would face practical hurdles in preserving unambiguous links to decades of published literature and clinical records. The system's complexity is thus best understood as a trade-off between historical continuity and everyday usability, with no simple consensus on how to resolve it.
Weighing Different Typing Approaches
Comparing HLA typing approaches is complicated by the fact that older and newer methods answer different questions. Serologic and cellular methods broadly characterized antigens as they were recognized historically, while DNA-based methods define alleles at far higher resolution. In practice, the method of choice depends on the clinical goal, with definitive, high-resolution results generally favored where precise tissue matching is required. No single method is optimal in every setting, which is why laboratories often shift from one technique to another as the demands of the case change.
Why Does HLA Nomenclature Matter for Your Health?
Understanding the HLA system and its nomenclature has significant implications for various aspects of health and medicine:
Nomenclature as the Product of the Field's Own Evolution
In a review of HLA nomenclature authorship, experts note that the need for a standardized nomenclature to define HLA polymorphism was recognized from the beginning of the field. HLA nomenclature therefore evolved alongside the methods used to detect and define that polymorphism, moving from serologic and cellular assays to DNA sequencing. The review attributes the complexity of the current system to this historical layering, the complexity of the HLA system itself, and the level of resolution required for modern applications. In short, today's naming scheme is best understood as the accumulated product of the field's own evolution.
Incremental Refinement Over Radical Overhaul
Looking ahead, the most likely developments in HLA nomenclature involve incremental refinement rather than wholesale overhaul. As typing technologies continue to advance and the known catalog of alleles grows, naming systems will need periodic updates to remain clinically useful. The ongoing series of formal nomenclature reports suggests that review cycles will continue, even if the pace and scope of changes remain uncertain. Any future restructuring would have to be weighed against the value of continuity with decades of existing literature.
Systemic Pressures on a Global Naming Authority
More broadly, HLA nomenclature sits at the intersection of immunology, transplantation, and public health, where even minor naming inconsistencies can ripple into clinical decisions. The challenges the field faces are systemic, including coordinating a global naming authority, keeping databases current with quickly accumulating sequence data, and making the system navigable for newcomers. These pressures are unlikely to disappear, since they stem from the inherent complexity of the HLA system itself. Addressing them will require sustained collaboration across laboratories, databases, and the bodies that govern nomenclature.
Names That Drive Real Clinical Decisions
Behind the technical complexity of HLA nomenclature lie real clinical stakes. The names attached to HLA variants are read daily by laboratory scientists and clinicians who must translate them into decisions about tissue matching and patient care. Because the system evolved to serve those decisions, its ongoing refinement matters not only to researchers but to the people whose treatment depends on accurate typing. Conveying that history clearly, as educational efforts attempt to do, can help practitioners and patients alike navigate a system that is as human as it is scientific.
<ul> <li><b>Organ Transplantation:</b> HLA matching is crucial for successful organ transplantation. Accurate HLA typing reduces the risk of rejection and improves patient outcomes.</li> <li><b>Disease Susceptibility:</b> Certain HLA alleles are associated with an increased risk of autoimmune diseases like type 1 diabetes, rheumatoid arthritis, and multiple sclerosis. Knowing your HLA type can help assess your risk.</li> <li><b>Personalized Medicine:</b> HLA typing can inform personalized treatment strategies, particularly in cancer immunotherapy and drug response.</li> </ul>
By staying informed about the latest HLA nomenclature and research, you can take a more active role in managing your health and understanding your genetic predispositions. As the field continues to evolve, resources like the IPD-IMGT/HLA Database (www.ebi.ac.uk/ipd/imgt/hla) will be invaluable for accessing the most current information.